Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C)

Clinical trial NCT06390839 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT06390839

Sponsor

National Cancer Institute (NCI)

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-03-22

Primary completion

2022-01-15

Enrollment

43

View on ClinicalTrials.gov